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Abstract: 
Current space programs are shifting toward planetary exploration, and in particular 
towards human missions to the moon and Mars. However, space radiation is a major 
barrier to human exploration of the solar system because the biological effects of high-
energy and charge (HZE) ions, which are the main contributors to radiation risks in deep 
space, are poorly understood. Predictions of the nature and magnitude of the risks posed 
by space radiation are subject to very large uncertainties. Great efforts have been 
dedicated worldwide in recent years toward a better understanding of the oncogenic 
potential of galactic cosmic rays. A review of the new results in this field will be 
presented here. 
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Introduction 
 
Space exploration is a grand adventure for humankind with the potential for exciting 
discoveries that capture our imaginations and benefit society. The benefits from 
exploration1 must be balanced with cost, safety and ethical concerns in deciding on 
acceptable levels of risks for astronauts or a no-go mission decision. The leading health 
concerns are exposure to galactic cosmic rays (GCR) and solar proton events, which 
present significant but poorly understood risks for carcinogenesis and degenerative 
diseases2,3. Spaceflight in low Earth orbit, such as missions on the space shuttle and the 
International Space Station, are partially protected by the Earth’s magnetic field and the 
solid shielding of the planet. The Apollo missions ventured away from the protection of 
the Earth but lasted only up to 12 days. Proposed missions to the moon in the next decade 
could last up to 200 days (figure 1) and a possible mission to Mars lasting as long as 3 
years would lead to whole body doses around 1-sievert (Sv) or more4. However, the 
concepts used for risk projection on Earth, including the use of the dose unit Sv, are 
perhaps deceptive for GCR exposures.  Efforts to improve the understanding of 
biological effects of densely ionizing heavy ions through biomedical research on cancer 
are the subject of this essay.  
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Space Radiation Environments and Risk Assessment 
 
In space, astronauts are exposed to protons and high energy and charge (HZE) ions along 
with secondary radiation including neutrons and high linear energy transfer (LET) recoil 
nuclei, produced by nuclear reactions in spacecraft or tissue. The energy spectrum of the 
GCR peaks near 1,000 MeV/nucleon, and consequently these particles are so penetrating 
that shielding can only partially reduce the doses absorbed by the crew. Thick shielding 
poses obvious mass problems to spacecraft launch systems, and would only reduce the 
GCR effective dose by no more than 25% using aluminum, or about 35% using the more 
efficient polyethylene. Therefore, current shielding approaches cannot be considered a 
solution for the space radiation problem with the exception of solar proton events, which 
are effectively absorbed by shielding4. 
  In traveling to Mars, every cell nucleus within an astronaut would be traversed by 
a proton or secondary electron every few days, and an HZE ion about once per month5. 
Whole body doses of 1-2 mSv/day accumulate in interplanetary space, and approximately 
half this value on planetary surfaces6. The large ionization power of HZE ions makes 
them the major contributor to the risk, in spite of their lower cell nucleus hit frequency 
than protons. To undertake ground-based space radiation research, special facilities are 
needed to accelerate charged particles (from protons to iron) to relativistic energies. Only 
a few such facilities exist in the world, and NASA has invested in a new facility at 
Brookhaven National Laboratory on Long Island, NY 
(http://www.bnl.gov/medical/NASA/). 
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  On Earth radiation workers or patients are most frequently exposed to low-LET γ- 
or X-rays. Epidemiological data, largely from the Atomic bomb survivors in Japan7, 
provides a basis for risk estimation for low-LET radiation. However, because no human 
data exist for protons and HZE ions, space risk estimates must rely entirely on model 
systems and biophysical considerations. Using standard methods for cancer risks 
projections based on the double detriment life table for an average population and a 
radiation induced cancer mortality rate scaled to the data from Atomic bomb survivors, 
risks for extended missions to the moon and the Mars exploration mission are shown in 
Table I. In this Table, 95% confidence intervals are reported that take into account the 
uncertainties in epidemiology data, space environments, and radiation quality and dose-
rate effectiveness factors. Maximum acceptable levels of risks for astronauts are typically 
set at 3% fatal risk2,3, but the large uncertainties in projections and the likelihood of other 
fatal or morbidity risks for degenerative diseases precludes a go/no-go decision for Mars 
exploration at this time.  
 
Radiobiology of HZE Ions- Cellular Effect 
 
A necessary step for reducing uncertainties in risk assessment are studies on the 
molecular pathways causative of cancer initiation and progression, and to extend these 
studies to learn how such pathways can be disrupted by HZE ions including both genetic 
and epigenetic modifications (figure 2). The goal of this research is to establish a more 
mechanistic approach to estimating of risk, and answering questions that include: can 
HZE effects be scaled from those of γ-rays, is risk linear with low dose-rate, and how 
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does individual radiation sensitivity impact risks for astronauts, a population selected for 
many factors related to excellence in health.  
As a starting point we can consider the initial biophysical events caused by HZE 
tracks in cells and tissue6,8,9. Energy deposition by HZE ions is highly heterogeneous with 
a localized contribution along the trajectory of each particle and lateral diffusion of 
energetic electrons (delta-rays) many microns from the ions path. These particles are 
therefore characterized by a high LET, however contain a low LET component. 
Biophysical models have shown that the energy deposition events by high LET radiation 
produce differential DNA lesions, including complex DNA breaks, and that there are 
qualitative differences between high- and low-LET radiation both in the induction and 
repair of DNA damage10-13. The number of DNA single strand breaks (SSB) and double 
strand breaks (DSB) produced by radiation varies little with radiation type8,10; however 
for high-LET radiation, a higher fraction of DNA damages are complex, i.e. clusters 
containing mixtures of two or more of the various types of damages (SSB, DSB, etc.) 
within a localized region of DNA. Complex damage is uncommon for endogenous 
damage or low-LET radiation, and has been associated with the increased relative 
biological effectiveness (RBE) of densely ionizing radiation. The repair of DSB is known 
to occur through direct end-joining and homologous recombination processes. Indications 
are that for high-LET radiation, where complex DSB occur with high frequency, little 
repair occurs leading to cell death or that the mis-rejoining of un-repairable ends with 
other radiation-induced DSB lead to large DNA deletions and chromosome aberrations.  
While the high effectiveness in cell killing provides the rationale for heavy-ion cancer 
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therapy (hadrontherapy)14, residual damage in surviving cells is of concern for 
carcinogenesis. 
Heavy charged particles are very effective at producing chromosomal exchanges 
with RBE values exceeding 30 in interphase (as visualized using premature chromosome 
condensation) and 10 at the first post-irradiation mitosis for energetic iron ions15. The 
detailed RBE versus LET relationship found for total exchanges is similar to earlier 
studies of mutation16 and in vitro neoplastic transformation17. For all of these endpoints, 
RBE peaks around 100-200 keV/µm, and then decreases at very high LET. However, the 
quality of chromosome damage is different when heavy ions are compared to sparsely 
ionizing radiation. Large differences in gene expression are observed between X-rays and 
HZE ions reflecting differences in damage response pathways18,19. Qualitative differences 
in the type of gene mutations have also been reported20. Novel multi-color fluorescence 
painting techniques of human chromosomes have clearly demonstrated that high-LET α-
particles21 and iron ions22,23 induce many more complex-type chromosomal exchanges in 
human cells than low-LET radiation (figure 3). Most of these complex chromosomal 
rearrangements will ultimately lead to cell death. In fact, only a small fraction of the 
initial damage is transmitted in mice 2-4 months after the exposure to energetic iron 
ions24. A low RBE for the induction of late chromosomal damage has also been measured 
in the progeny of human lymphocytes exposed in vitro to energetic iron ions, with the 
interesting exception of terminal deletions, that occurred with much higher frequency in 
the progeny of cells exposed to heavy ions compared to γ-rays25. 
The presence of chromosomes lacking telomeres in the progeny of cells exposed 
to heavy ions is particularly interesting. Sabatier et al.26 found that rearrangements 
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involving telomere regions are associated with chromosomal instability in human 
fibroblasts many generations after exposure to accelerated heavy ions. Telomere 
dysfunction play a crucial role in initiating or sustaining genomic instability27-28, which is 
a major step in cancer progression. Heavy ion-induced effects on telomere stability has 
also been studied using siRNA knockdown for components of DNA-dependent protein 
kinase (DNA-PK) in human lymphoblasts29. Differential results where found for γ−rays 
and high-LET radiation, with iron nuclei being much more effective in producing DSB-
telomere fusions after knockdown of DNA-PK.  Cells containing telomere-deficient 
chromosomes will either senesce, or undergo B/F/B cycles, promoting genetic instability. 
The fate of normal cells containing a single terminal deletion is not known, but it has 
been shown that the loss of a single telomere in cancer cells can result in instability in 
multiple chromosomes30. These recent results suggest that telomere instability could be 
an important early event in the pathway to cancer induction by HZE nuclei.  
 
Radiobiology of HZE Ions- Tissue Effects 
 
The possibility of heavy ions causing unique tissue damage at low dose was noted after 
the Apollo astronauts’ observed of light flashes during dark adaptation31. These visual 
sensations are related to the passage of HZE particles through the retina, or proton-
induced nuclear interactions in the eye32. The micro-lesion concept considers stochastic 
tissue events that occur with HZE tracks and the possibility of unique types of tissue 
damage9. Micro-lesion formation is of especial concern for damage to the brain or central 
nervous system (CNS), where fully differentiated structures are present. However, it 
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could also play a role in increased effectiveness for HZE ions in highly structured tissues. 
CNS effects that have been observed in animal models include altered motor function or 
performance33, accelerated striatal aging34, late degradation of DNA35, altered dopamine 
function33, and neurodegeneration36. The Casarett model37,35 predicts that the appearance 
of late degenerative effects to the CNS and other tissues could be advanced by many 
years after radiation exposure in what has been called “radiation accelerated aging”. This 
effect would have an increasing severity with increasing HZE fluence, and appears to be 
relevant in describing the increased incidence of cataracts observed in astronauts exposed 
to higher doses of space radiation38.  
  Animal studies generally demonstrate that HZE nuclei have a higher carcinogenic 
effectiveness than low-LET radiation. RBE was measured in mice or rats for tumors of 
the skin39 and of Harderian40 or mammary41 gland, and reaches values as high as 25-40 at 
low doses. However, the risk and detriment of cancer is not fully characterized until the 
relationship between radiation quality and latency, where tumors appear earlier after 
high-LET irradiation42, is adequately described.   Recent studies have debated the relative 
importance of DNA damage and mutation or extracellular matrix remodeling and other 
non-targeted effects as initiators of carcinogenesis43.  Tissue effects independent of DNA 
damage that have been associated with cancer initiation or progression include genomic 
instability44, extracellular matrix remodeling43, persistent inflammation43, and oxidative 
damage45. Other studies are exploring possible relationships between radiation and the 
activation of dormant tumors and modulation of angiogenesis46.  
The so-called bystander or non-targeted effects45,47,48 may have enormous 
consequences for space exploration. Non-targeted effects may lead to supra-linear dose-
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response curve at low doses, perhaps reducing the effectiveness of spacecraft shielding, 
but it may also be protective by removing damaged cells from the organism. Both effects 
challenge the conventional linear no-threshold risk model assumption49, which is 
currently adopted for radioprotection on Earth and in space. They also suggest important 
targets for biological countermeasures likely to be more effective than countermeasures 
targeting DNA damage50.  
 
Conclusions 
 
Reducing the uncertainties in risk assessment required before a mission to Mars can be 
undertaken has led to a great number of investigations guided by molecular and genetic 
research on carcinogenesis and degenerative diseases. The large uncertainties in risk 
projection models will only be reduced by improving basic understanding of the 
underlying biological processes and their disruption by space radiation. There are unique 
aspects involved in this approach due to the specific challenges to biological systems 
presented by space radiation, especially HZE ions. It is unlikely that the radiation risk 
problem for space exploration will be solved by a simple countermeasure, such as 
shielding or radioprotective drugs. The risk will be understood and controlled only with 
more basic research in the field of cancer induction by charged particles. 
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Table 1. Calculations of effective doses, %Risk of death from fatal cancer, and 95% CI for lunar or Mars missions. 
Calculations are at solar minimum where GCR fluence is highest for a 5-g/cm2 aluminum shield. The absorbed dose, D and 
Effective dose, E are averaged over tissues prominent for cancer risk2, and competing causes of death are treated in the risk 
calculation, compressing the distribution of risk probabilities at larger values (>5%). 
 
Exploration mission D, Gy E, Sv Fatal Risk(%) 95% CI 
    Males (40 y)
Lunar (180 d) 0.06 0.17 0.68 [0.20, 2.4] 
Mars swingby (600 d) 0.37 1.03 4.0 [1.0, 13.5] 
Mars exploration (1000 d) 0.42 1.07 4.2 [1.3, 13.6] 
 Females (40 y) 
Lunar (180 d) 0.06 0.17 0.82 [0.24, 3.0] 
Mars swingby (600 d) 0.37 1.03 4.9 [1.4, 16.2] 
Mars exploration (1000 d) 0.42 1.07 5.1 [1.6, 16.4] 
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Figure 1. Concept of a future moon landing. According to the new Vision for Space 
Exploration (January 2004), NASA plans to return on the moon within the year 2020. 
The current project anticipates 4-6 crewmembers performing Lunar surface operations for 
60-180 days. The Earth-moon cruise lasts approximately 4 days. (Picture credit 
NASA/John Frassanito and associates). 
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Figure 2. Schematic of importance of uncovering basic mechanisms of cancer induction 
by galactic cosmic radiation. Determining role of DNA damage vs. non-targeted effects 
has large implications for radiation shielding, mission duration, and in approaches to 
design of biological countermeasures. In DNA-target model, a linear response is expected 
with research focus on slope of response as function of radiation quality and radiation 
sensitivity. In non-targeted model, shielding is ineffective and distinct target for 
biological countermeasures are pursued.  
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Figure 3. A karyotype of a human lymphocyte exposed to 0.3 Gy Fe-ions (1 
GeV/nucleon). The cell contain a non-reciprocal exchange involving chromosomes 2, 3, 
and 4. Complex-type exchanges are very rarely seen after exposure to low-LET radiation 
at doses <2Gy, but can be induced by single traversals of heavy ions. 
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